Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia– reperfusion injury in rats by targeting multiple cellular processes

Neuropsychiatric Disease and Treatment

Volumn 13, Issue , 2017, Pages 927-935

  Wang, Mingyang ^a   Zhang, Yi ^a   Feng, Lu ^a   Zheng, Ji ^a   Fan, Shujie ^a   Liu, Junya ^a   Yang, Nan ^a   Liu, Yanyong ^a   Zuo, Pingping ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cerebral ischemia reperfusion; Compound porcine cerebroside and ganglioside injection; Multitarget; Neuroprotection

Indexed keywords

CELL PROTEIN; CEREBROSIDE; COMPLEXIN 1; COMPLEXIN 2; COMPOUND PORCINE CEREBROSIDE AND GANGLIOSIDE; GANGLIOSIDE; GINATON; GINKGO BILOBA EXTRACT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KIFC2; PROTEIN SNAP25; SYNAPTOPHYSIN; SYNTAXIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL FUNCTION; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 85018481209     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S129522     Document Type: Article

References (44)

1. Goldstein LB, Rothwell PM. Advances in prevention and health services delivery. Stroke. 2008;39(2):258–260.
2. Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7(5):378–385.
3. Broussalis E, Killer M, McCoy M, Harrer A, Trinka E, Kraus J. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention. Drug Discov Today. 2012; 17(7–8):296–309.
4. Fisher M. New approaches to neuroprotective drug development. Stroke. 2011;42(1 Suppl):S24–S27.
5. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges, and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399–415.
6. Pandya RS, Mao L, Zhou H, et al. Central nervous system agents for ischemic stroke: neuroprotection mechanisms. Cent Nerv Syst Agents Med Chem. 2011;11(2):81–97.
7. Sims NR, Anderson MF. Mitochondrial contributions to tissue damage in stroke. Neurochem Int. 2002;40(6):511–526.
8. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta. 2010;1802(1):80–91.
9. Nuñez-Figueredo Y, Ramírez-Sánchez J, Hansel G, et al. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo. Neuropharmacology. 2014;85:517–527.
10. Kwak DH, Kim SM, Lee DH, et al. Differential expression patterns of Gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. Mol Cells. 2005;20(3):354–360.
11. Davis CK, Laud PJ, Bahor Z, Rajanikant GK, Majid A. Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke. J Cereb Blood Flow Metab. 2016;36(10): 1686–1694.
12. Zamfir AD. Neurological analyses: focus on gangliosides and mass spectrometry. Adv Exp Med Biol. 2014;806:153–204.
13. Ohmi Y, Tajima O, Ohkawa Y, et al. Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. Proc Natl Acad Sci U S A. 2009;106(52): 22405–22410.
14. Posse de Chaves E, Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584(9):1748–1759.
15. Li L, Tian J, Long MK, et al. Protection against experimental stroke by ganglioside GM1 is associated with the inhibition of autophagy. PLoS One. 2016;11(1):e0144219.
16. Mo L, Ren Q, Duchemin AM, Neff NH, Hadjiconstantinou M. GM1 and ERK signaling in the aged brain. Brain Res. 2005;1054(2):125–134.
17. Rajanikant GK, Zemke D, Senut MC, et al. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke. 2007;38(11): 3023–3031.
18. Bae ON, Serfozo K, Baek SH, et al. Safety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke. Stroke. 2013;44(1):205–212.
19. Baek SH, Noh AR, Kim KA, et al. Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage. Stroke. 2014;45(8):2438–2443.
20. Pekcetin C, Kiray M, Ergur BU, et al. Carnosine attenuates oxidative stress and apoptosis in transient cerebral ischemia in rats. Acta Biol Hung. 2009;60(2):137–148.
21. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res. 2010;13(2–3):156–158.
22. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84–91.
23. Zhang R, Yang N, Ji C, et al. Neuroprotective effects of Aceglutamide on motor function in a rat model of cerebral ischemia and reperfusion. Restor Neurol Neurosci. 2015;33(5):741–759.
24. Wang MY, Feng L, Fan SJ, et al. [Effect of Compound Porcine Cerebroside and Ganglioside Injection on cerebral ischemia-reperfusion injury in rats]. Chin J Rehabil Theory Pract. 2016;22(7):750–753. Chinese.
25. Yin B, Xu Y, Wei R, Luo B. Ginkgo biloba on focal cerebral ischemia: a systematic review and meta-analysis. Am J Chin Med. 2014;42(4): 769–783.
26. Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005–1011.
27. Germano AF, Dixon CE, d’Avella D, Hayes RL, Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma. 1994;11(3):345–353.
28. Dang S, Liu X, Fu P, et al. Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats. Neurol Res. 2011;33(5):520–528.
29. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10(2):290–293.
30. Yu XQ, Xue CC, Zhou ZW, et al. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci. 2008;82(1–2):68–78.
31. Wang JP, Yang ZT, Liu C, He YH, Zhao SS. L-carnosine inhibits neuronal cell apoptosis through signal transducer and activator of transcription 3 signaling pathway after acute focal cerebral ischemia. Brain Res. 2013;1507:125–133.
32. Tarsa L, Goda Y. Synaptophysin regulates activity dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A. 2002;99(2):1012–1016.
33. Saito N, Okada Y, Noda Y, Kinoshita Y, Kondo S, Hirokawa N. KIFC2 is a novel neuron-specific C-terminal type kinesin superfamily motor for dendritic transport of multivesicular body-like organelles. Neuron. 1997;18(3):425–438.
34. Antonucci F, Corradini I, Fossati G, Tomasoni R, Menna E, Matteoli M. SNAP-25, a known presynaptic protein with emerging postsynaptic functions. Front Synaptic Neurosci. 2016;8:7.
35. Trimbuch T, Rosenmund C. Should I stop or should I go? The role of complexin in neurotransmitter release. Nat Rev Neurosci. 2016;17(2): 118–125.
36. Zhang J, Fang X, Zhou Y, et al. The possible damaged mechanism and the preventive effect of monosialotetrahexosylganglioside in a rat model of cerebral ischemia-reperfusion injury. J Stroke Cerebrovasc Dis. 2015;24(7):1471–1478.
37. Park HS, Han KH, Shin JA, Park JH, Song KY, Kim DH. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. J Korean Neurosurg Soc. 2014;55(3):125–130.
38. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J. 2000;345 Pt 2: 161–179.
39. Ozcan C, Palmeri M, Horvath TL, Russell KS, Russell RR. Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning. Am J Physiol Heart Circ Physiol. 2013;304(9): H1192–H1200.
40. Tamm I, Schriever F, Dörken B. Apoptosis: implications of basic research for clinical oncology. Lancet Oncol. 2001;2(1):33–42.
41. Tong T, Ji J, Jin S, et al. Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol Cell Biol. 2005;25(11):4488–4500.
42. Zhang D, Zhang W, Li D, Fu M, Chen R, Zhan Q. GADD45A inhibits autophagy through regulating the interaction between BECN1 and PIK3C3. Autophagy. 2015;11(12):2247–2258.
43. Regehr WG. Short-term presynaptic plasticity. Cold Spring Harb Perspect Biol. 2012;4(7):a005702.
44. Rizo J, Xu JJ. The synaptic vesicle release machinery. Annu Rev Biophys. 2015;44:339–367.